CD274 and neoplasm: Multiple reports suggest that treatment success using therapeutic antibodies targeting an immune checkpoint PD‐L1 or PD‐1 depends on the expression of PD‐L1 in lung tumors, including tumor cells and/or tumor‐associated cells (Herbst et al, 2014; Garon et al, 2015; Hirsch et al, 2016).